The Use of Coenzyme Q10 in Cardiovascular Diseases.
Level 5 - mechanism / opinion, no new human data
Narrative review summarizing mechanisms and clinical evidence without systematic review methodology
PubMed 34068578 · doi:10.3390/antiox10050755
What was done
This narrative review summarized the physiological role of coenzyme Q10 (CoQ10) in mitochondrial bioenergetics and antioxidant defense, along with clinical evidence supporting its therapeutic use in cardiovascular diseases, endothelial dysfunction, and coronary artery bypass graft surgery.
What was found
The abstract reports that prolonged CoQ10 supplementation is safe and significantly increases plasma CoQ10 concentration to 3–5 µg/mL. It states that CoQ10 reduces oxidative stress and cardiovascular mortality, improves clinical outcomes in bypass surgery, prevents oxidized LDL accumulation, decreases vascular stiffness and hypertension, and improves endothelial function by lowering reactive oxygen species and raising nitric oxide levels. Specific effect sizes, numerical comparisons, and confidence intervals are not provided in the abstract.
Why it matters
It provides a concise overview of the mechanistic rationale and reported clinical applications of CoQ10 supplementation in age-related cardiovascular conditions.
Limits
As a narrative review, it lacks a systematic search protocol, risk of bias assessment, and quantitative meta-analysis. The number of included studies, sample sizes, patient populations, and numerical effect sizes for clinical endpoints are not reported in the abstract.
Cited by
- supports Omega-3 fatty acids and co-enzyme Q10 support cardiovascular health, cellular energy production, and brain health.
- supports Omega-3 fatty acids and coenzyme Q10 support cardiovascular health, cellular health and energy, and brain health.